Proteinase K Market (By Therapeutic Area Outlook- Infectious Diseases, Diabetes, Oncology, Cardiology, Nephrology, Autoimmune Diseases, Neurology, and Others. By Form- Powder, and Liquid. By Geography-North America, Europe, Asia Pacific, Latin America, Middle East, and Africa) - Global Industry analysis, size, share, growth, trends, and forecast, 2021 - 2031.

The Global Proteinase K Market was valued at $67.2 Million in 2020. Growing at a high CAGR of more than 5.3% between 2021 and 2031, it is estimated to reach $121.3 Million by 2031. However, the current pandemic of COVID-19 might make a slight difference in the growth rate in the present year. Proteinase K is a serine protease generated by the fungus Tritirachium album Limber. It is used as a reagent or enzyme in different chemical reactions. The rising prevalence of chronic diseases is anticipated to drive the market over the forecast period. Apart from that, the rising demand for gene therapy across the globe is the primary factor for market growth. In addition to this, the robust demand for the global Proteinase K market in the healthy drink department is further estimated to create new necessities and augment the market of growth over the forecast period of 2021-2031. 

Global Proteinase K Segment Is Estimated to Witness Remarkable Growth

Source: SAI Research

The Proteinase K market is segmented as therapeutic area outlook and form. Based on Therapeutic Area Outlook, the global Proteinase K market has been divided into Infectious Diseases, Diabetes, Oncology, Cardiology, Nephrology, Autoimmune Diseases, Neurology, and Others. Based on Form, the global Proteinase K market has been bifurcated as Powder and Liquid.

By Region, North America is Holding the Major Market Share

The Proteinase K Market has been geographically segmented into North America, Asia Pacific, Latin America, Middle East, Europe, and Africa region. In addition to this, North America has a significant share among those regions. The increasing prevalence of cancer led to increasing next-generation sequencing and polymerase chain reaction application, which is the prime factor for the market growth over the globe. The growing initiative health program, rising research centers, and increasing investment are the factors in the development of the market. Increasing disposal incomes, availability of advanced technology, and other potential factors drive the market over the forecast period. Apart from that, Europe and the Rest of the regions are expected to increase the growth rate in the upcoming forecast period of 2021 to 2031. 

Major Players in the Global Proteinase K Market

The report covers a detailed outlook about the company, and it includes the company or industry profiles and market share of key players operating in the global market. Key players in the report include Merck KGaA; Codexis, Inc.; F. Hoffmann-La Roche Ltd.; Amano Enzyme Inc.; Advanced Enzymes Technologies Ltd.; Biocatalysts Ltd.; Amicogen; Dyadic International; BBI Solutions; Affymetrix; American Laboratories, New England Biolabs, Worthington Biochemical Corporation, Norgen Biotek Corp., BIORON GmbH among others.

The Global Proteinase K Market Has Been Segmented into:

Global Proteinase K Market: By Therapeutic Area Outlook

• Infectious Diseases
• Diabetes
• Oncology
• Cardiology
• Nephrology
• Autoimmune Diseases
• Neurology
• Others

Global Proteinase K Market: By Form

• Powder
• Liquid

Global Proteinase K Market: By Region

• North America
  • USA
  • Canada
  • Mexico
  • Rest of North America
• Europe
  • UK
  • Germany
  • France
  • Spain
  • Italy
  • Russia
  • Rest of Europe
• Asia Pacific
  • India
  • China
  • Japan
  • South Korea
  • Rest of Asia Pacific
• Latin America, Middle East & Africa
  • Brazil
  • South Africa
  • UAE
  • Rest of LAMEA